Authorization Letter. Chiron will allow Gen-Probe to directly access OEM suppliers of eSAS-2 Instruments to purchase or modify eSAS- 2 Instruments for the Clinical Diagnostic Field. Chiron will not make any agreement with sub-contract manufacturers that will restrict Gen-Probe’s ability to negotiate its own contract with the vendors for the manufacture and purchase of modified eSAS- 2 Instruments for the Clinical Diagnostic Field. In addition, the Parties acknowledge that Gen-Probe shall have the right to purchase the eSAS 2 Instrument from any Third Party that Chiron employs to manufacture the eSAS 2 Instrument. Promptly following the execution of an agreement between Chiron and a Third Party for the manufacture of the eSAS 2 Instrument, and at Gen-Probe’s written request, Chiron shall execute the authorization letter attached hereto as Schedule 6.4 (“Sales Authorization Letter”).
Appears in 2 contracts
Sources: Modified Blood Screening Instrument Esas 2 Addendum (Gen Probe Inc), Modified Blood Screening Instrument – Esas 2 Addendum (Chiron Corp)